DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Coenzyme A is an investigational drug.
There have been 4 clinical trials for Coenzyme A. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2010.
The most common disease conditions in clinical trials are Hyperlipidemias, Hyperlipoproteinemias, and [disabled in preview]. The leading clinical trial sponsors are Zhejiang University and [disabled in preview].
There are two US patents protecting this investigational drug and twenty-two international patents.
Recent Clinical Trials for Coenzyme A
|The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia||Zhejiang University||Phase 2/Phase 3|
|Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia||Zhejiang University||Phase 3|
|Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia||Zhejiang University||Phase 3|
Top disease conditions for Coenzyme A
Top clinical trial sponsors for Coenzyme A
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Coenzyme A||Start Trial||Methods of expressing products in mammalian cells||INTREXON CEU, INC. (Blacksburg, VA)||Start Trial|
|Coenzyme A||Start Trial||Markers for inflammatory bowel disease||UNIVERSITY OF OTTAWA (Ottawa, ON, CA)||Start Trial|
|Coenzyme A||Start Trial||Variety corn line GAQ2025||Syngenta Participations AG (Basel, CH)||Start Trial|
|Coenzyme A||Start Trial||Compounds useful for the treatment of metabolic disorders and synthesis of the same||North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)||Start Trial|
|Coenzyme A||Start Trial||Protein kinase C inhibitors and uses thereof||Rigel Pharmaceuticals, Inc. (South San Francisco, CA)||Start Trial|
|Coenzyme A||Start Trial||Engineered strain of Escherichia coli for production of poly-R-3-hydroxyalkanoate polymers with defined monomer unit composition and methods based thereon||The Research Foundation for The State University of New York (Albany, NY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Coenzyme A||World Intellectual Property Organization (WIPO)||2012027533||2030-08-25||Start Trial|
|Coenzyme A||Australia||2015327681||2034-10-03||Start Trial|
|Coenzyme A||Canada||2962802||2034-10-03||Start Trial|
|Coenzyme A||European Patent Office||3201622||2034-10-03||Start Trial|
|Coenzyme A||World Intellectual Property Organization (WIPO)||2016049772||2034-10-03||Start Trial|
|Coenzyme A||Canada||2947084||2035-11-13||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|